Board Allots 1,82,400 Equity Shares on Conversion of 60,800 Warrants

Fredun Pharmaceuticals has allotted 1,82,400 equity shares of face value Rs. 10/- each to 10 Non-Promoter allottees.

Mon 5 Oct 2026

Equity Shares Allotted

1,82,400 equity shares of face value Rs. 10/- each

Number of Allottees

10 Non-Promoter allottees

Warrants Converted

60,800 warrants

Bonus Issue Adjustment

1:2 bonus issue proportionately adjusted the entitlement

Issue Price per Warrant

Rs. 1,250/- per warrant

What the company informed the exchange

Fredun Pharmaceuticals has told BSE that its board, at a meeting held on October 03, 2026, allotted 1,82,400 fully paid-up equity shares of face value Rs. 10/- each to 10 Non-Promoter allottees.

How the conversion worked

• Shareholders approved the preferential issue at an Extra-Ordinary General Meeting held on October 22, 2025.
• Convertible warrants were allotted on a preferential basis on December 29, 2025.
• The warrant holders paid the balance consideration and applied to exercise their right to convert 60,800 warrants into 1,82,400 equity shares.

Price and payment terms

• Issue price: Rs. 1,250/- per warrant.
• Rs. 312.50/- per warrant, being 25% of the issue price, was payable upfront.
• The balance consideration has been received, and the equity shares are allotted pursuant to exercise of the conversion.

Effect of the bonus issue

Following the company's 1:2 bonus issue, the entitlement attached to the outstanding warrants was adjusted. Pursuant to that adjustment, 60,800 outstanding warrants were exercisable into 1,82,400 equity shares, i.e. three equity shares for each outstanding warrant, on payment of the applicable balance consideration.

Allottee-wise position

The update lists a total of 72,000 convertible warrants allotted on December 29, 2025, 60,800 shares allotted upon conversion, 2,667 warrants outstanding for conversion and 1,82,400 shares after the effect of the bonus issue. The after-bonus entitlement of the individual allottees is:

• Girdhari T Jaisinghani: 48,000
• Nikhil R Jaisinghani: 48,000
• R. R. Family Trust: 40,800
• Rashmi Jain: 12,000
• Rinkle Jain: 12,000
• Swati Goel: 8,000
• Divya Aggarwal: 6,400
• Reshma M Kukreja: 2,400
• Juhi H. Ramnani: 2,400
• Karina C Moriani: 2,400

Total: 1,82,400

What else the update says

• The equity shares will be allotted in dematerialised form and will rank pari passu with the existing equity shares of the company in all respects.
• The instruments being converted were convertible warrants issued on a preferential basis under Chapter V of the SEBI ICDR Regulations, 2018 and other applicable law.
• The board meeting commenced at 04:00 p.m. and concluded at 05:15 p.m.

The takeaway for a retail reader

This is the completion step of a warrant conversion that was set in motion earlier: warrant holders have paid the balance and the shares now stand allotted. The company's total number of equity shares goes up by the shares allotted, and since the allottees are Non-Promoter holders, the shareholding pattern changes accordingly. A reader tracking the company can note the new share count and the allottee-wise distribution given above.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.